MoU signed to begin plasma treatment of COVID-19 patients


From Zeeshan Mirza

KARACHI: Pakistan will use plasma immunisation for the first time to treat coronavirus patients as a memorandum of understanding (MoU) was signed between a government-run Jinnah Postgraduate Medical Centre (JPMC) and National Institute of Blood Diseases (NIBD), media reported on Tuesday.
The MoU was signed by Dr Seemi Jamali, the executive director of the Jinnah Postgraduate Medical Centre (JPMC), and Professor Dr Tahir Shamsi from National Institute of Blood Diseases and Bone Marrow Transplantation (NIBD). It is decided to commence plasma therapy of COVID-19 patients at Jinnah Hospital. The document obtained by media read, “This Memorandum of Understanding (MoU) sets forth the continuation of understandings between the name parties to pursue “Experimental Use of Convalescent Plasma In Treating Critically Ill Patients With Covid-19 Disease.”

Dr Tahir Shamsi said that the procedure would improve the critically ill patients with COVID-19 disease within two to three days after the administration of convalescent plasma. It is pertinent to mention here that the plasma immunisation is being used in many countries by using blood donated by recovered patients for introducing anti-bodies in those COVID-19 patients receiving treatment.